NBP · NASDAQ
NovaBridge Biosciences (NBP) Stock Price & Fundamentals
NovaBridge Biosciences (NBP) closed at $215.17 on Oct 9, 2026, up 1.04% from the previous close of $212.96.
Share price, past year
1Y −5.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $215.17 |
| Sep 30, 2026 | $208.47 |
| Aug 31, 2026 | $212.11 |
| Jul 31, 2026 | $228.75 |
| Jun 30, 2026 | $227.11 |
| May 29, 2026 | $220.83 |
| Apr 30, 2026 | $222.86 |
| Mar 31, 2026 | $213.96 |
| Feb 27, 2026 | $206.89 |
| Jan 30, 2026 | $204.95 |
| Dec 31, 2025 | $204.28 |
| Nov 28, 2025 | $215.32 |
| Oct 31, 2025 | $219.91 |
Key statistics
- Market cap
- $57.10B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 265.4M
- Dividend yield
- —
- 52-week range
- $198.74 – $234.59
NovaBridge Biosciences's market cap is $57.10B, based on a share price of $215.17 and 265.4M shares outstanding as of Dec 31, 2025.
Financials
NovaBridge Biosciences reported revenue of $632.00K for fiscal 2023, up 140.75% from fiscal 2022.
NovaBridge Biosciences reported a net loss of $46.27M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2023ended Dec 31, 2023 | $632.00K | +140.8% | −$207.73M | −32,868.5% | −$1.09 | −$183.96M |
| FY2022ended Dec 31, 2022 | −$1.55M | −111.2% | −$371.05M | 23,923.5% | −$1.96 | −$161.98M |
| FY2021ended Dec 31, 2021 | $13.81M | −94.2% | −$365.87M | −2,648.7% | −$2.09 | −$157.40M |
| FY2020ended Dec 31, 2020 | $236.42M | +5,386.8% | $72.17M | 30.5% | $0.46 | $65.22M |
| FY2019ended Dec 31, 2019 | $4.31M | — | −$208.56M | −4,840.1% | −$28.90 | −$126.44M |
Company profile
- Name
- NovaBridge Biosciences
- Ticker
- NBP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Suite 400, 2440 Research Blvd, Rockville, MD 20850
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001778016
Frequently asked questions
What is NovaBridge Biosciences's stock price?
NovaBridge Biosciences (NBP) closed at $215.17 on Oct 9, 2026, up 1.04% from the previous close of $212.96.
What is NovaBridge Biosciences's market cap?
NovaBridge Biosciences's market cap is $57.10B, based on a share price of $215.17 and 265.4M shares outstanding as of Dec 31, 2025.
How much revenue does NovaBridge Biosciences make?
NovaBridge Biosciences reported revenue of $632.00K for fiscal 2023, up 140.75% from fiscal 2022.
Sources and methodology
Fundamentals come from NovaBridge Biosciences's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures